Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311532875> ?p ?o ?g. }
- W4311532875 endingPage "8502" @default.
- W4311532875 startingPage "8502" @default.
- W4311532875 abstract "The concept of polypharmacology embraces multiple drugs combined in a therapeutic regimen (drug combination or cocktail), fixed dose combinations (FDCs), and a single drug that binds to different targets (multi-target drug). A polypharmacology approach is widely applied in the treatment of acquired immunodeficiency syndrome (AIDS), providing life-saving therapies for millions of people living with HIV. Despite the success in viral load suppression and patient survival of combined antiretroviral therapy (cART), the development of new drugs has become imperative, owing to the emergence of resistant strains and poor adherence to cART. 3'-azido-2',3'-dideoxythymidine, also known as azidothymidine or zidovudine (AZT), is a widely applied starting scaffold in the search for new compounds, due to its good antiretroviral activity. Through the medicinal chemistry tool of molecular hybridization, AZT has been included in the structure of several compounds allowing for the development of multi-target-directed ligands (MTDLs) as antiretrovirals. This review aims to systematically explore and critically discuss AZT-based compounds as potential MTDLs for the treatment of AIDS. The review findings allowed us to conclude that: (i) AZT hybrids are still worth exploring, as they may provide highly active compounds targeting different steps of the HIV-1 replication cycle; (ii) AZT is a good starting point for the preparation of co-drugs with enhanced cell permeability." @default.
- W4311532875 created "2022-12-26" @default.
- W4311532875 creator A5000506024 @default.
- W4311532875 creator A5012054411 @default.
- W4311532875 creator A5033718762 @default.
- W4311532875 creator A5049366282 @default.
- W4311532875 creator A5069833831 @default.
- W4311532875 creator A5080260057 @default.
- W4311532875 creator A5081931507 @default.
- W4311532875 date "2022-12-03" @default.
- W4311532875 modified "2023-10-16" @default.
- W4311532875 title "The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands for AIDS Therapy" @default.
- W4311532875 cites W1578932543 @default.
- W4311532875 cites W166112135 @default.
- W4311532875 cites W1808513053 @default.
- W4311532875 cites W1965757633 @default.
- W4311532875 cites W1974197466 @default.
- W4311532875 cites W1974445593 @default.
- W4311532875 cites W1975337790 @default.
- W4311532875 cites W1981775239 @default.
- W4311532875 cites W1985667653 @default.
- W4311532875 cites W1992134901 @default.
- W4311532875 cites W1994217580 @default.
- W4311532875 cites W1994607156 @default.
- W4311532875 cites W2020378451 @default.
- W4311532875 cites W2022424773 @default.
- W4311532875 cites W2022963171 @default.
- W4311532875 cites W2028733293 @default.
- W4311532875 cites W2029898962 @default.
- W4311532875 cites W2032596641 @default.
- W4311532875 cites W2034952754 @default.
- W4311532875 cites W2049995666 @default.
- W4311532875 cites W2053724945 @default.
- W4311532875 cites W2056357424 @default.
- W4311532875 cites W2059933091 @default.
- W4311532875 cites W2072290017 @default.
- W4311532875 cites W2075025456 @default.
- W4311532875 cites W2092885068 @default.
- W4311532875 cites W2094970257 @default.
- W4311532875 cites W2095193361 @default.
- W4311532875 cites W2098605123 @default.
- W4311532875 cites W2102732416 @default.
- W4311532875 cites W2129873851 @default.
- W4311532875 cites W2138017354 @default.
- W4311532875 cites W2139752232 @default.
- W4311532875 cites W2142577277 @default.
- W4311532875 cites W2149638276 @default.
- W4311532875 cites W2159596974 @default.
- W4311532875 cites W2161497618 @default.
- W4311532875 cites W2172339798 @default.
- W4311532875 cites W2329046360 @default.
- W4311532875 cites W2333399282 @default.
- W4311532875 cites W2419592716 @default.
- W4311532875 cites W2577017727 @default.
- W4311532875 cites W2594396234 @default.
- W4311532875 cites W2734601307 @default.
- W4311532875 cites W2790160600 @default.
- W4311532875 cites W2841751732 @default.
- W4311532875 cites W2899426458 @default.
- W4311532875 cites W2911848688 @default.
- W4311532875 cites W2922229918 @default.
- W4311532875 cites W2936714912 @default.
- W4311532875 cites W2949238281 @default.
- W4311532875 cites W2953379328 @default.
- W4311532875 cites W2954167186 @default.
- W4311532875 cites W2974793213 @default.
- W4311532875 cites W2982387087 @default.
- W4311532875 cites W3035889410 @default.
- W4311532875 cites W3036304309 @default.
- W4311532875 cites W3047466768 @default.
- W4311532875 cites W3083821209 @default.
- W4311532875 cites W3087530754 @default.
- W4311532875 cites W3094724038 @default.
- W4311532875 cites W3107156107 @default.
- W4311532875 cites W3131462776 @default.
- W4311532875 cites W3210632115 @default.
- W4311532875 cites W4371618829 @default.
- W4311532875 cites W2082922635 @default.
- W4311532875 doi "https://doi.org/10.3390/molecules27238502" @default.
- W4311532875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36500608" @default.
- W4311532875 hasPublicationYear "2022" @default.
- W4311532875 type Work @default.
- W4311532875 citedByCount "2" @default.
- W4311532875 countsByYear W43115328752023 @default.
- W4311532875 crossrefType "journal-article" @default.
- W4311532875 hasAuthorship W4311532875A5000506024 @default.
- W4311532875 hasAuthorship W4311532875A5012054411 @default.
- W4311532875 hasAuthorship W4311532875A5033718762 @default.
- W4311532875 hasAuthorship W4311532875A5049366282 @default.
- W4311532875 hasAuthorship W4311532875A5069833831 @default.
- W4311532875 hasAuthorship W4311532875A5080260057 @default.
- W4311532875 hasAuthorship W4311532875A5081931507 @default.
- W4311532875 hasBestOaLocation W43115328751 @default.
- W4311532875 hasConcept C126322002 @default.
- W4311532875 hasConcept C142462285 @default.
- W4311532875 hasConcept C159047783 @default.
- W4311532875 hasConcept C2776999253 @default.
- W4311532875 hasConcept C2780035454 @default.